Christian Keller, MS, MBA

Christian Keller, MS, MBA

CEO

Christian Keller received his MBA from Stanford School of Business, his MS in Electrical and Computer Engineering from Georgia Tech, and a Diplome d’Ingenieur from Supelec (France). Christian brings extensive managerial expertise with his previous experience as a Senior Project Manager at PG&E and a marketing and sales healthcare consultant at ZS Associates. Christian is excited to be part of a team that is developing a technology capable of identifying novel DNA biomarkers that will allow clinicians to better prevent and treat cancer.

Sylvain Costes, Ph.D.

Sylvain Costes, Ph.D.

Co-Founder and CSO

Dr. Costes received his Ph.D. in Nuclear engineering from UC Berkeley in 1999. After his postdoctoral fellowship in the Mathematics Department at UC Berkeley, he joined the National Cancer Institute where he developed novel quantitative tools for fluorescence 4D microscopy. Dr. Costes joined the Lawrence Berkeley National Laboratory in 2004, where he developed under DOE and NASA funding, the novel technology being used by Exogen to assess DNA repair in human cells. He has over 40 peer-reviewed publications on high-throughput fluorescence microscopy, DNA damage quantification, image analysis and computer modeling for radiation risk. Dr. Costes is the Physics council for the Radiation Research Society and was recently awarded the 2014 Visionary Award from the Berkeley Chamber of Commerce for his work at Exogen.

Thomas Deschamps, Ph.D.

Thomas Deschamps, Ph.D.

Sr Data Scientist

Dr. Deschamps received his Ph.D. in Applied Mathematics and Image Processing jointly from Université Paris-IX and Philips Research Labs. After his postdoctoral fellowship in the Mathematics Department at UC Berkeley and Lawrence Berkeley National Lab working on microscopy imaging, he joined the startup Terarecon as a Sr Research Engineer in medical imaging diagnostic applications. He worked for General Electric Healthcare as a Team leader for all cardiovascular imaging applications. In his last role, Dr Deschamps was a diplomat in charge of developing R&D partnerships between the US and French public-private entities for the Pacific North-West. Dr Deschamps is the first author of many journal, conference papers and international patents on medical image processing. He's an expert on medical software development, artificial intelligence, data analysis, and the recipient of an O-1 Visa: Individuals with Extraordinary Ability or Achievement.

Tony Tin, Ph.D.

Tony Tin, Ph.D.

Scientist, Cancer Biology

Tony received his Ph.D. in 2013 from UC Berkeley, where he discovered preventative and therapeutic strategies to treat cancer stem cells. Dr. Tin is a cancer biology scientist at Exogen Biotechnology helping to refine our DNA health assays. While publishing first author papers, writing conference abstracts, and earning speaking awards during his academic career, Tony simultaneously consulted for many prominent startups in the SF area. Prior to joining Exogen, he was a project manager at LS Tech where he developed highly efficient and cost effective methods of manufacturing consumer and healthcare products for Fortune 50 companies. Combining his scientific background with his practical business experience, Tony brings invaluable expertise to the Exogen team.